| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9437 | 
      | Human Intestinal Absorption | HIA+ | 0.9767 | 
      | Caco-2 Permeability | Caco2- | 0.6179 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7405 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9421 | 
                                                     | Non-inhibitor | 0.9666 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9225 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6070 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.6049 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8078 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5388 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8681 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9973 | 
                                                                    | Non-inhibitor | 0.9057 | 
      | AMES Toxicity | Non AMES toxic | 0.7521 | 
      | Carcinogens | Non-carcinogens | 0.6382 | 
      | Fish Toxicity | High FHMT | 0.5644 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.5901 | 
      | Honey Bee Toxicity | Low HBT | 0.6486 | 
      | Biodegradation | Not ready biodegradable | 0.8732 | 
      | Acute Oral Toxicity | III | 0.5858 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6826 |